Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Sheridan

Showing results (51-60 of 367) with videos related to

Pageof 37
Sort By:
The Oncologist|May 5, 2000
Development of GnRH antagonists for prostate cancer: new approaches to treatmentT Cook, W P Sheridan
Journal of Chemical Information and Modeling|July 28, 2005
Enhanced virtual screening by combined use of two docking methods: getting the most on a limited budgetVladimir Maiorov, Robert P Sheridan
Clinical Chemistry|March 1, 1979
Interpretation of serum total triiodothyronine in relation to binding proteinsP Sheridan, R B Payne
British Medical Journal|October 21, 1978
Thyroid function testsP Sheridan, R B Payne
British Medical Journal|January 20, 1973
Side effects of benorylateA J Marshall, P Sheridan
Proteins|September 1, 1992
A systematic search for protein signature sequencesR P Sheridan, R Venkataraghavan
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1991
The role of colony stimulating factors in cancer therapyG Morstyn, W P Sheridan
Australian and New Zealand Journal of Medicine|August 1, 1991
Chronic myeloid leukaemia treated by allogeneic bone marrow transplantation from histocompatible sibling donors--an invariably fatal malignancy rendered highly curableJ Szer, W P Sheridan
The New England Journal of Medicine|April 19, 1979
Thyroid hormone binding proteins in chronic active hepatitisP Sheridan, M S Losowsky
Lancet (London, England)|October 30, 1976
Assessment of paracetamol poisoningR B Payne, P Sheridan
Pageof 37

Showing results (51-60 of 367) with videos related to

Sort By:
Pageof 37
The Oncologist|May 5, 2000
Development of GnRH antagonists for prostate cancer: new approaches to treatmentT Cook, W P Sheridan
Journal of Chemical Information and Modeling|July 28, 2005
Enhanced virtual screening by combined use of two docking methods: getting the most on a limited budgetVladimir Maiorov, Robert P Sheridan
Clinical Chemistry|March 1, 1979
Interpretation of serum total triiodothyronine in relation to binding proteinsP Sheridan, R B Payne
British Medical Journal|October 21, 1978
Thyroid function testsP Sheridan, R B Payne
British Medical Journal|January 20, 1973
Side effects of benorylateA J Marshall, P Sheridan
Proteins|September 1, 1992
A systematic search for protein signature sequencesR P Sheridan, R Venkataraghavan
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1991
The role of colony stimulating factors in cancer therapyG Morstyn, W P Sheridan
Australian and New Zealand Journal of Medicine|August 1, 1991
Chronic myeloid leukaemia treated by allogeneic bone marrow transplantation from histocompatible sibling donors--an invariably fatal malignancy rendered highly curableJ Szer, W P Sheridan
The New England Journal of Medicine|April 19, 1979
Thyroid hormone binding proteins in chronic active hepatitisP Sheridan, M S Losowsky
Lancet (London, England)|October 30, 1976
Assessment of paracetamol poisoningR B Payne, P Sheridan
Pageof 37